NZ747726A - Nicotine particles - Google Patents

Nicotine particles

Info

Publication number
NZ747726A
NZ747726A NZ747726A NZ74772617A NZ747726A NZ 747726 A NZ747726 A NZ 747726A NZ 747726 A NZ747726 A NZ 747726A NZ 74772617 A NZ74772617 A NZ 74772617A NZ 747726 A NZ747726 A NZ 747726A
Authority
NZ
New Zealand
Prior art keywords
nicotine
particles
less
micrometres
particle size
Prior art date
Application number
NZ747726A
Inventor
Nicolo Volpe
Original Assignee
Philip Morris Products Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication of NZ747726A publication Critical patent/NZ747726A/en
Application filed by Philip Morris Products Sa filed Critical Philip Morris Products Sa

Links

Abstract

method includes combining nicotine with a liquid carrier to form a liquid mixture and spray drying the liquid mixture to form a first plurality of particles. The first pluralities of particles are then milled to form a second plurality of particles.

Description

NICOTINE PARTICLES This disclosure relates to nicotine particles that are suitable for inhalation. The nicotine particles are formed by spray drying followed by milling.
Dry powder rs (DPI) are known and are used to treat respiratory diseases by delivering a dry powder comprising a pharmaceutically active compound, in aerosol form h inhalation to the ts’ airways. ln pharmaceutical dry powders, the active pharmaceutical ingredient (API) is usually agglomerated on the surface of larger carrier particles, such as lactose for example. DPl’s operate complex mechanisms to ensure such agglomerates disperse, break up or disaggregate before the API is inhaled into the lungs.
It may be difficult to deliver nicotine particles to the lungs at inhalation at air flow rates that are within conventional smoking regime tion or air flow rates. Nicotine particles may have a tendency to agglomerate and stick to inhaler or processing surfaces, especially as a size of the nicotine particle deceases. Nicotine particles with an MMAD of less than about 10 micrometres tend to be increasingly thermodynamically unstable due to a high surface area to volume ratio, which provides an increasing e free energy with this decreasing le size, and consequently ses the tendency of particles to agglomerate and the strength of the agglomerate. Forming nicotine particles may be difficult and costly. ne particles may be ting when inhaled and may induce a cough reflex. Cough suppressants such as menthol have been added to nicotine particle compositions. These cough suppressants may have a tendency to agglomerate the nicotine particles and cause stickiness of the composition. This may lead to handling and storage concerns of the nicotine particle compositions.
It would be desirable to provide nicotine particles that may reduce or mitigate a cough reflex when inhaled and provide an enhanced tion experience. It would be desirable that the nicotine particles be formed and processed easily and exhibit a stable particle size distribution. It may be desirable that the ne particles be free of a cough ssant Nicotine particles may be formed by spray drying a liquid mixture to form a first plurality of particles. The liquid mixture ses nicotine. The liquid mixture may also comprise a W0 2018l002779 sugar, or an amino acid, or both a sugar and amino acid. The liquid e may comprise a short peptide comprising 2 or 3 amino acid. The first plurality of particles is then milled to form a second plurality of particles.
The second plurality of nicotine particles may have a particle size distribution where about 90% the plurality of particles have a le size of less than about 2.8 micrometres, and about 50% of the plurality of particles have a particle size of less than about 1.35 micrometres, and about 10% of the second plurality of particles having a particle size of less than about 0.65 micrometres.
Preferably the milling step is performed with a fluid energy mill. The fluid energy mill may 1O decrease an average particle size or mass median aerodynamic diameter of the ne particles.
Advantageously, the method described herein utilizes a spray dryer to provide nous nicotine particles that can be further reduced in size with a fluid energy mill to achieve a specific and controlled le size distribution. This method advantageously maximizes product yield in a cost effective manner. The final size distribution of the second plurality of nicotine particles may be stable over time and form a le composition. The final size distribution of the second plurality of nicotine particles is sufficient to deliver nicotine to the lungs at inhalation or air flow rates that are within conventional smoking regime inhalation or air flow rates, to provide an enhanced tion experience The term “nicotine” refers to ne and nicotine tives in any form, including but not d to, a free-base nicotine, nicotine salt, or in a matrix such as a sugar matrix or organometallic complex.
The term “amino acid" refers to a single unmodified or modified amino acid moiety, preferably unmodified.
The term “short peptide" refers to a peptide comprising two or three amino acids.
The phrase “fluid energy milling” refers to particle size reduction by colliding particle streams. Fluid energy milling includes air jet milling or jet milling.
W0 02779 The phrase “plurality of particles” unless otherwise specified, means the first plurality of particles, the second plurality of les, or both the first and the second plurality of particles.
The size of a particle, stated , preferably refers to the aerodynamic diameter of the particle. The aerodynamic diameter of a powder system is ably measured with a cascade impactor. The term “MMAD” refers to the mass median aerodynamic diameter.
This disclosure relates to nicotine particles that are suitable for inhalation and methods for forming the same. These nicotine particles may provide for gentle or smooth inhalation without inducing or minimizing a cough reflex. The nicotine particles may be formed by spray drying a liquid mixture to form a first ity of particles. The liquid mixture comprises nicotine The liquid mixture may also se a sugar, or an amino acid, or both a sugar and amino acid. Spray drying the liquid mixture may form a homogenous first plurality of particles. The first plurality of particles may then be milled (preferably with a fluid energy mill) to form a second plurality of particles having a size distribution that is reduced as compared to the size distribution of the first plurality of particles. The second ity of nicotine les may have a particle size distribution where about 90% (by ) of the plurality of particles have a particle size of less than about 2.8 micrometres, and about 50% of the plurality of les have a particle size of less than about 1.35 micrometres, and about 10% of the second plurality of particles having a particle size of less than about 065 micrometres. The percentages relating to particle size distribution bed herein are based on particle volume (% by volume) A dry powder composition may be formed form these nicotine particles. An inhalation delivery consumable element may contain the nicotine particles or dry powder composition described herein.
The combination of spray drying followed by milling (preferably fluid energy milling) advantageously provides nicotine particles that may be flowable, have a specific, controlled and stable particle size distribution and provide an enhanced inhalation experience, Spray drying forms a first ity of particles having a first size distribution. Advantageously, milling or fluid energy milling decreases an e particle size of the particles, Milling or fluid energy milling utilizes the first ity of particles and forms a second plurality of particles having a second size distribution, The second size distribution is preferably reduced as compared to the first size distribution.
W0 02779 The nicotine may be ved in the liquid carrier to form the liquid mixture. Sugar may be dissolved in the liquid carrier to form the liquid e. An amino acid may be dissolved in the liquid carrier to form the liquid mixture. A short peptide may be ved in the liquid carrier to form the liquid mixture.
Spray drying utilizes a spray or atomization nozzle to atomize a liquid mixture (under pressure) and evaporate liquid carrier from the liquid mixture. The resulting dry les may be id shaped within a designed particle size distribution.
Fluid energy milling is a size reduction unit operation that utilizes colliding fluid streams (for example gas or compressed gas or air) carrying particles. The colliding fluid streams provide particle to particle impact to facilitate size reduction. There are generally no moving parts in a fluid energy mill and generally no mechanical forces act on the particles during size reduction.
Fluid energy or jet mills are typically capable of reducing solids to particle sizes in the low—micron to submicron range. The size reduction energy is typically created by gas streams from horizontal grinding air nozzles. Typically, particles in the fluidized bed created by the gas streams are accelerated towards the center of the mill, colliding with slower moving particles or particles moving in a different direction. The gas streams and the particles carried in them typically create a violent turbulence and as the particles e with one another they are reduced in size.
The second plurality of particles may be formed by fluid energy milling or ing air streams with entrained ne particles. Preferably, the particle compositions of colliding air streams are substantially similar and homogenous. Fluid energy milling may increase the amount of respirable nicotine particles (particles able to reach the lungs) as compared to spray dried only nicotine particles. Fluid energy milling may increase this amount by at least about 10% or at least about 20% or at least 30%.
The fluid energy milling step may reduce the particle size or average le size or particle size distribution by about 10% or greater, or about 20% or greater. Larger particles may be d a greater amount than smaller les in the same size distribution. For example the 90% size threshold may be reduced (from the first size distribution 90% threshold to the W0 2018l002779 2017/053710 second size distribution 90% threshold) by about 10% or greater, or about 20% or greater, or about 30% or greater, or in a range from about 10% to about 40%, or from about 20% to about 40%.
The fluid energy milling step may reduce the mass median aerodynamic diameter of the first plurality of particles to a mass median aerodynamic diameter of the second plurality of particles by a ratio of about 1.1:1 to about 10:1, or about 1.21 to about 5:1, or about 1.221 to about 3.6:1, or about 151 to about 3:1, or about 3:1, or about 2:1.
Preferably, the ratio of the mass median aerodynamic diameter of the first ity of particles to the mass median aerodynamic diameter of the second plurality of particles is 1O between about 1.1:1 to about 10:1, or about 1.221 to about 5:1, or about 1.221 to about 3.6:1, or about 1.5:1 to about 3:1, or about 3:1, or about 2:1.
The first plurality of particles may comprise about 90%, or about 95%, or about 98% of particles having an aerodynamic diameter of about 4.5 etres or less. The first plurality of particles may comprise at least about 50% of particles having an aerodynamic diameter of about 2.5 micrometres or less. The first plurality of les may comprise at least about 10% of particles having an namic diameter of about 0.85 micrometres or less. The first plurality of particles may have a mass median aerodynamic diameter in a range from about 1 to about 4 micrometres. Substantially all of the first plurality of particles may have an aerodynamic diameter in a range from about 500 nanometers to about 5 micrometres.
Fluid energy milling reduces the size of the first plurality of particles to form a second plurality of les. The second plurality of particles may comprise at least about 90%, or about 95%, or about 98% of particles having an aerodynamic diameter of about 3 micrometres or less, or 2.8 etres or less. The second plurality of particles may comprise at least about 50% of particles having an aerodynamic diameter of about 1.5 micrometres or less, or 1.35 micrometres or less. The second plurality of particles may comprise at least about 10% of particles having an aerodynamic diameter of about 0.7 micrometres or less, or 0.65 micrometres or less. The second plurality of particles may have a mass median aerodynamic diameter in a range from about 1 to about 2.5 micrometres. Substantially all of the second plurality of particles may have an aerodynamic diameter in a range from about 500 ters to about 3 micrometres.
W0 2018l002779 The nicotine component of the particle may be a free base nicotine, a ne salt, or a combination thereof. The nicotine component may be a nicotine salt formed by combining nicotine or nicotine free base with an acid. The acid may be a stoichiometric amount of acid to the nicotine free base, or a stoichiometric excess of acid may be combined with the nicotine free base, or a stoichiometric excess of nicotine free base may be combined with the acid. A free base nicotine may be utilized without the addition of an acid.
The acid may be an organic acid, an inorganic acid, or a Lewis acid. miting es of inorganic acids are hydrochloric, hydrobromic, odic, nitric, sulfuric, phosphoric, acetic, hexafluorophosphoric, and the like. miting es of organic acids are levulinic, citric, gluconic, benzoic, nic, butyric, alicylic, maleic, lauric, malic, fumaric, succinic, tartaric, amsonic, pamoic, mesylic, aspartic, formic, acetic, propionic, succinic, camphorsulfonic, fumaric, isethionic, , mucic, para-toluenesulfonic, glycolic, glucuronic, maleic, furoic, glutamic, benzoic, anthranilic, salicylic, phenylacetic, pyruvic, mandelic, embonic (pamoic), methanesulfonic, ethanesulfonic, pantothenic, esulfonic (besylate), stearic, sulfanilic, alginic, uronic, and the like. Non-limiting examples of Lewis acids are zinc de or zinc bromide (ZnCI: / ZnBrz). These can react with nicotine to form organometallic complexes.
Useful nicotine salts include, but are not limited to, nicotine pyruvate, nicotine citrate, nicotine aspartate, nicotine lactate, nicotine bitartrate, nicotine salicylate, nicotine fumarate, nicotine mono-pyruvate, ne glutamate or nicotine hydrochloride, for example. Preferred nicotine salts include, nicotine lactate, nicotine pyruvate, nicotine citrate, nicotine aspartate, or a combination thereof.
The pH of the plurality of particles (dissolved in water) may be in a range from about 5 to about 9. Preferably the pH is about 7.0 or higher or in a range from 7.0 to 9.0. A pH of 9 can be reached for a particle without c acid, while a pH of 5.0 can be obtained with the use of a strong acid or diacid when forming the nicotine salt.
The ity of particles may include an amino acid or peptide (preferably formed of three or less amino acids). The amino acid or peptide may reduce adhesion forces of the particles and mitigate or prevent agglomeration of the particles during formation or subsequent handling, The particles may form be a free flowing material and may possess a stable relative le size distribution during sing, transport and storage.
W0 2018l002779 Useful amino acids may include leucine, alanine, valine, isoleucine, methionine, phenylalanine, tyrosine, tryptophan, or a combination thereof. One red amino acid is leucine or a leucine isomer such as, L—leucine. A useful peptide includes trileucine, for e The plurality of particles may e a sugar. Sugar refers to simple sugars, monosaccharides, disaccharides, and ccharides. Without limitation, examples of suitable sugars are lactose, sucrose, raffinose, ose, fructose, dextrose, glucose, maltose, mannitol, or combinations thereof. Preferred sugars include trehalose or mannitol.
The plurality of particles may contain less than about 30 wt% nicotine. The plurality of particles may contain about 25 wt% or less nicotine or from about 15 to about 25 wt% nicotine. 1O The plurality of particles may n from about 1 to about 20 wt% nicotine or from about 10 to about 20 wt% nicotine, or from about 5 to 15 wt% nicotine. The plurality of les may contain from about 1 to about 10 wt% nicotine or from about 5 to about 10 wt% nicotine.
The plurality of particles may contain about 1 to about 10 wt% amino acid. The plurality of particles may contain about 3 to about 7 wt% amino acid. The plurality of particles may contain from about 5 wt% amino acid. The addition of the amino acid, especially L—leucine for example, to the particles may reduce agglomeration or adherence to processing es.
The plurality of particles may contain about 60 to about 95 wt% sugar. The plurality of particles may contain about 70 to about 90 wt% sugar.
Useful ne particles include an amino acid being leucine, a sugar being trehalose, and a nicotine salt being nicotine lactate. The nicotine content may be from about 5 to about 15 wt% or about 9.5 wt%. The leucine content may be from about 3 to about 7 wt% or about 5 wt%. The molar ratio of acid:nicotine may be about 1:1.
Useful nicotine particles include an amino acid being leucine, a sugar being trehalose, and a nicotine salt being nicotine e. The ne content may be from about 5 to about 15 wt% or about 9.6 wt%. The e content may be from about 3 to about 7 wt% or about 5 wt%. The molar ratio of acid:nicotine may be about 0.25:1.
Useful nicotine particles include an amino acid being leucine, a sugar being trehalose, and a nicotine salt being nicotine pyruvate. The nicotine content may be from about 5 to about W0 2018l002779 wt% or about 9.8 wt%. The leucine content may be from about 3 to about 7 wt% or about 5 wt%. The molar ratio of acid:nicotine may be about 0.6:1.
Useful nicotine particles include an amino acid being leucine, a sugar being trehalose, and a nicotine salt being nicotine ate. The nicotine content may be from about 5 to about wt% or about 9.3 wt%. The leucine content may be from about 3 to about 7 wt% or about 5 wt%. The molar ratio of acidznicotine may be about 06:1.
The particles may be formed by: (1) combining a nicotine, and optionally a sugar and an amino acid or peptide in a liquid r to form a liquid mixture; (2) spray drying the liquid mixture to form a first plurality of particles having a size in a range from about 0.5 to about 10 1O micrometres or in a range from about 0.5 to about 5 micrometres; and (3) milling the first plurality of particles to form a second plurality of particles, Preferably the milling unit operation is a fluid energy milling unit operation that reduces the size of the particles. it has been found that preparing particles comprising nicotine by spray drying and then milling (especially fluid energy milling) could improve the inhalation experience or mitigate or reduce perceived harshness or a cough reflex associated with inhaling spray dried nicotine particles. The examples below illustrate that that the perceived feel during inhalation of the spray dried and further milled nicotine particles (with no cough ssant such as l) compares favourably to spray dried and unmilled nicotine particles with 5% l cough suppressant.
The plurality of particles may be free of a cough suppressant material. The plurality of nicotine particles may comprises less than 5%, or less than 1%, or less than 0.1% by weight of cough suppressant (such as menthol), or be free of cough suppressant (such as menthol).
The liquid r may be water, for example. The liquid mixture is flowable. The liquid mixture is configured to flow h an atomization or atomizer nozzle to form a first plurality of particles Then the first plurality of particles is fluid energy milled to form the precise size distribution of second plurality of particles, described .
The plurality of particles described herein may form a dry powder composition and be packaged for consumption. The les described herein may form a dry powder composition and be packaged in an inhalation ry consumable element or contained within an inhalation delivery consumable element. An inhalation delivery consumable element may be a capsule, for W0 2018l002779 example. The capsule may be by disposed in an inhalation device, such as a dry powder inhaler. The inhalation device may pierce the capsule and the particles may be entrained in the inhalation air for delivery to the lungs of a consumer.
The plurality of particles or dry powder composition described herein and the inhalation ry consumable element may be free of, or substantially free of carrier particles. The plurality of les described herein and the inhalation delivery consumable t may be free of, or substantially free of particles that are greater than about 20 etres, or greater than about 50 etres, or greater than about 100 micrometres.
The plurality of les described herein may be processed at a reduced (as compared to conventional nicotine particles) temperature that may result in reduced product loss. The spray drying inlet temperature and the outlet temperature may be d. The spray drying atomization pressure may be in a range from about 3 to about 7 bar, or 4 to about 6 bar, or about 5 bar.
The spray drying inlet temperature may be about 140 degrees Celsius or less, or about 135 degrees Celsius or less, or about 130 degrees Celsius or less, or in a range from about 100 to about 150 degrees Celsius, or in a range from about 110 to about 140 degrees Celsius, or in a range from about 125 to about 135 degrees Celsius. The spray drying outlet temperature may be about 100 degrees s or less, or about 95 degrees Celsius or less, or about 90 degrees Celsius or less, about 85 degrees Celsius or less, or about 80 degrees Celsius or less, or in a range from about 30 to about 90 degrees s, or in a range from about 40 to about 90 degrees s, or in a range from about 50 to about 85 degrees Celsius.
The second plurality of particles may be formed by fluid energy milling the first plurality of particles formed by the spray drying unit operation. The first plurality of particles may be processed with a fluid energy mill by colliding the first plurality of particles with each other to form the second plurality of particles or particles.
The first plurality of les (formed by the spray drying process) may be fluid energy milled at a temperature of about 50 degrees Celsius or less, or about 40 degrees Celsius or less, or about 30 degrees Celsius or less, about 20 degrees Celsius or less, or about 10 degrees s or less, or in a range from about -20 to about 40 degrees Celsius, or in a range W0 2018l002779 from about —10 to about 30 degrees Celsius, or in a range from about 0 to about 30 degrees Celsius.
The reduction in particle size by fluid energy milling may be increased by fluid energy g at lower temperatures. The particles may tend to be more brittle at lower atures, and may therefore fracture more y so that the milled les tend to be smaller at lower temperatures. The first plurality of particles (formed by the spray drying process) may be fluid energy milled at a temperature below room temperature, ably at a ature below about 20 degrees Celsius, or below about 10 degrees Celsius, or below about 0 degrees Celsius. 1O Fluid energy milling may be carried out at milling or ng pressures between about 0.1 and about 12 bar. Varying the pressure allows control over the amount of particle size reduction. The milling pressure may be in a range from about 1 to about 7 bar, or about 2 to about 6 bar, or about 3 to about 5 bar, or about 4 bar. Particle feed pressure may be greater than the milling pressure. Feed pressure may be in a range from about 5 to about 13 bar, or about 5 to about 10 bar, or about 6 to about 8 bar, or about 7 bar.
Fluid energy milling may be carried out in two or more stages, to e the cial effects of the milling at different pressures. The use of multiple steps may allow one to tailor the properties of the fluid energy milled particles to suit a particular inhaler device or to target particular parts of the lung.
An additive al can be combined with the first plurality of particles and processed in the fluid energy mill. Combining an additive material with the first plurality of particles may be termed “co-jet or co-fluid energy” milling. The additive may coat the particles, depending on the milling pressure.
The fluid energy mill may be any useful type of fluid energy mill. Useful fluid energy mills include, for example, an Atritor M3 Spiral jet mill. a A850 Spiral jet mill, a MC50 Hosakawa Microniser, other spiral jet mills, pancake jet mills or opposed fluid bed jet mills. The feed rate for the fluid energy mill will depend on the size of the mill. Small spiral jet mills may use a feed rate of, for example, about 1 to about 4 g per minute, whilst industrial scale mills will have a feed rate in the order of kilograms per hour. Examples below utilize the Atritor M3 Spiral jet mill. This W0 2018;002779 fluid energy mill provided at r than about 90% product yield or less than about a 10% product loss.
The properties of the fluid jet milled particles may, to an extent, be ed or adjusted by making changes to the fluid jet milling unit ion. For example, the degree of particle size reduction may be adjusted by changing the number ofjets which are used in the fluid jet mill, or by adjusting their orientation, that is, the angles at which they are positioned.
All scientific and technical terms used herein have meanings commonly used in the art unless otherwise specified. The definitions provided herein are to facilitate understanding of certain terms used frequently herein.
As used herein, the singular forms it n it , an”, and “the" encompass embodiments having plural referents, unless the content clearly dictates ise As used herein, “or" is generally employed in its sense including “and/or” unless the content clearly es otherwise. The term “and/or” means one or all of the listed elements or a combination of any two or more of the listed elements.
As used , “have”, “having n uincluden ll ing 7) ncomprisen it , , , , comprising” or the like are used in their open ended sense, and generally mean “including, but not limited to”. It will be understood that “consisting essentially of”, “consisting of”, and the like are subsumed in “comprising," and the like.
The words “preferred” and “preferably” refer to embodiments of the invention that may afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances Furthermore, the recitation of one or more red embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the disclosure, including the claims. is a schematic flow diagram of an rative method 100 of g the particles 135. The method 100 includes combining nicotine 102, a sugar 104, and an amino acid or peptide 106 in a liquid carrier to form a liquid e 115 at block 110. Then, at block 120, the liquid mixture 115 is spray dried to form a first plurality of particles 125. Then the first plurality of 2017/053710 particles 125 is milled at block 130 (fluid energy milled, for example) to form a second ity of particles 135.
Examples All the examples t Table 3 examples) are formulated by combining nicotine base and acid in water (at the specified ratio) to form a stable nicotine salt solution. Then the sugar and amino acid (leucine) is combined with the nicotine salt solution to form a liquid mixture.
Then the liquid mixture is atomized and dried to form dry particles that are collected to from the dry powder composition.
The Table 3 examples are formulated by ing a nicotine free base with sugar and amino acid ne) to form a liquid mixture. Then the liquid e is atomized and dried to form dry particles that are collected to from the dry powder composition.
The spray dryer was a Buchi B-290 spray dryer (available from Buchi Corp., DE, USA).
The liquid mixture was provided to the spray dryer at a flow rate of 2 ml/min at 5 bar atomization pressure. The outlet temperature was about 80 degrees Celsius for examples utilizing trehalose. Table 1 below describes lactic acid nicotine powder formulations. Table 2 below describes pyruvic acid nicotine powder formulations. Table 3 below describes no acid nicotine powder formulations. Table 4 reports the particle size distribution of various examples.
Table 1 - Lactic Acid Nicotine Powder Formulations Example Formulation pH of Comments powder solution L1 10% Nicotine, Lactic acid (1:1), 7.3 Small amount of powder adhering 85% ose to spray dryer surface % Nicotine, Lactic acid (1 :1), Small amount of powder adhering 77% Trehalose to spray dryer surface L3 10% Nicotine, Lactic acid (1 :1), 7.5 Free flowing powder — no WO 20181002779 80% Trehalose, 5% Leucine ‘ nce L4 15% Nicotine, Lactic acid (1 :1), 7.1 Free flowing powder —- no 72% Trehalose, 5% Leucine adherence L5 20% Nicotine, Lactic acid (1:1), —— Free flowing powder — no 64% Trehalose, 5% Leucine adherence Table 2 - Pyruvic Acid Nicotine Powder Formulations e Formulation pH of Comments powder solution P1 10% Nicotine, Pyruvic acid (06:1), 7.5 Powder adhering to spray dryer 87% Trehalose surface, cohesive powder P2 15% Nicotine, Pyruvic acid (06:1), 7.8 Cohesive powder, some static 80% Trehalose charge P3 10% ne, Pyruvic acid (06:1), 7.7 Free flowing powder — no 82% Trehalose, 5% Leucine adherence, some static charge P4 15% Nicotine, Pyruvic acid (06:1), 7.8 Free flowing powder — no 75% Trehalose, 5% Leucine adherence P5 20% ne, Pyruvic acid (0.621), 7.7 Free flowing powder — no 68% Trehalose, 5% Leucine adherence WO 02779 Table 3 - No Acid Nicotine Powder Formulations Example Formulation pH of Comments powder N1 10% Nicotine, 90% Trehalose 9.3 Some powder adhering to spray dryer surface N2 15% Nicotine, 85% Trehalose 9.5 Some powder adhering to spray dryer surface N3 10% Nicotine, 85% Trehalose, 5% 8.6 Free flowing powder — no Leucine adherence, some static charge N4 15% Nicotine, 80% Trehalose, 5% 8.7 Free flowing powder — no Leucine nce N5 20% Nicotine, 75% Trehalose, 5% Free flowing powder — no Leucine adherence Table 4 — Particle Size Distribution — reported in micrometres Example X10 X50 X90 VMD L1 0.65 1.43 3.54 1.81 L2 0.68 1.62 3.75 1.97 L3 0.76 1.89 3.86 2.14 L4 0.92 2.14 3.99 2.35 L5 0.78 1.95 3.90 2.19 P1 0.67 1.54 3.47 1.85 P2 0.67 1.53 3.54 1.86 P3 0.66 1.48 3.54 1.84 P4 0.72 1.78 3.79 2.06 P4 0.65 1.43 3.54 1.81 N1 0.68 1.62 3.75 1.97 N2 0.76 1.89 3.86 2.14 N3 092 2.14 3.99 2.35 N4 0.78 1.95 3.90 2.19 N5 067 1.54 3.47 1.85 X10 refers to size of particle where 10% of particles, by volume, are less than this size.
X50 refers to size of particle where 50% of particles, by volume, are less than this size.
X90 refers to size of particle where 90% of particles, by volume, are less than this size.
VMD refers to volume mean diameter. le size distribution described herein was determined by Sympatec laser sizing, Andersen Cascade lmpactation, and ng on microscopy.
Table 5 — Further Formulations Example Formulation X10 X50 X90 VMD MMADJ 1 10% Nicotine, Lactic Acid (1:1), 092 2.17 4.15 2.4 3.8 80% Trehalose, 5% Leucine 2 10% Nicotine, Pyruvic Acid (1 :06), 1.04 2.56 5.08 2.9 4.0 82% Trehalose, 5% Leucine 3 10% Nicotine, Citric Acid 5), 0.81 2.34 5.48 2.8 3.5 82% Trehalose, 5% Leucine 4 10% Nicotine, Aspartic Acid (1:06), 0.82 2.24 4.96 2.6 4.2 80% Trehalose, 5% Leucine Fluid Energy Milling Examples The ing examples are formulated as bed above. Example 5 includes 5% wt menthol that is dissolved in ethanol and added to the liquid mixture. Example 6 is free of menthol.
The liquid mixture is atomized and dried with a spray dryer to form dry particles that are then fluid energy milled to from the dry powder composition.
The spray dryer was a Buchi B—290 spray dryer (available from Buchi Corp, DE, USA).
The liquid mixture was provided to the spray dryer at a flow rate of 2 ml/mln at 5 bar atomization pressure. The outlet temperature was about 80 degrees Celsius for examples ing trehalose.
The fluid energy mill was an Atritor M3 Fluid Energy Mill (available from Atritor d, England). The feed rate to the mill was about 3 grams per minute, using a compressed air driven venture feed at a pressure of about 7 bar and a milling pressure of about 4 bar, at room temperature. Example 5 was milled to create Example 5M and Example 6 was milled to create Example 6M.
Table 6 - Nicotine Powder Formulations Example Formulation pH of powder solution 5% Nicotine, Lactic Acid (1 :1), 7.3 82% Trehalose, 5% e, 5% Menthol 6 5% Nicotine, Lactic Acid (1 :1), 7-2 82% Trehalose, 5% Leucine Example 5 and Example 6 are then fluid energy milled as bed above. Prior to fluid energy milling Example 6 had a respirable particle fraction of 52% (able to reach the lungs 2017/053710 during inhalation). After fluid energy milling Example 6M had a respirable le fraction of 70% (able to reach the lungs during inhalation).
Table 7 ~ Particle Size Before and After Fluid Energy Milling Table 8 reports particle size distribution immediately following (t=0) and 7 days (t=7) following spray drying and fluid energy milling. Storage conditions were 40 degrees Celsius and 75% relative humidity (RH) for seven days.
Table 8 Example X10 X50 X90 VMD Moisture Content t=0 0.74 1.79 3.61 2.02 t 2.59 t=7 0.74 1.80 3.66 2.05 t 2.32 5M t=0 0.62 1.14 2.32 1.33 t 2.32 5M t=7 0.62 1.19 2.50 1.14 2.98 6 t=0 0.82 2.03 4.03 2.27 2.77 6 t=7 0.80 2.03 4.05 2.27 3.02 6M t=0 0.65 1.34 2.80 1.56 2.94 6M t=7 0.64 1.32 2.80 1.56 2.99 Expert panel tests were conducted on Example 5 and Example 6 and Example 6M.
Example 6M and Example 5 were deemed to be substantially equal in ved inhalation feel as compared to Example 6.
W0 2018l002779

Claims (15)

CLAIMS 1.:
1. A , comprising: combining nicotine with a liquid carrier to form a liquid e; and spray drying the liquid e to form a first plurality of particles; and milling the first plurality of nicotine particles to form a second plurality of particles.
2. The method according to claim 1, wherein the combining step further comprises combining a sugar and the nicotine with the liquid carrier to form the liquid mixture.
3. The method according to any one of the ing claims, wherein the combining step comprises combining an amino acid and the nicotine with the liquid carrier to form the liquid mixture. 15
4. The method according to any one of the preceding claims wherein the nicotine is a nicotine salt.
5. The method according to any one of the preceding claims, wherein the milling step ses fluid energy milling and the fluid energy milling decreases a mass median 20 aerodynamic diameter of the first plurality of particles to a mass median aerodynamic diameter of the second plurality of particles by a ratio of about 1.2:1 to about 5:1.
6. The method according to any one of the preceding claims, wherein the spray drying step forms a first plurality of nicotine particles sing about 90% by volume of the particles 25 having a particle size of about 4.5 micrometres or less, and about 50% by volume of the W0 2018l002779 particles having a particle size of less than about 2.5 etres and about 10% by volume of the particles having a particle size of less than about 0.85 micrometres.
7. The method according to any one of the preceding claims, wherein the milling step forms a second plurality of nicotine particles comprising about 90% by volume of the particles having a le size of less than about 3.0 micrometres, and about 50% by volume of the particles having a particle size of less than about 1.5 micrometres, and about 10% by volume of the particles having a particle size of less than about 0.7 micrometres. 10
8. The method according to claim 2, wherein the ne comprises nicotine e, nicotine pyruvate, nicotine citrate, or nicotine aspartate, and the sugar is trehalose.
9. The method according to claim 3, wherein the nicotine comprises nicotine lactate, nicotine pyruvate, nicotine citrate, nicotine aspartate, and the amino acid comprises leucine.
10. The method according to any one of the preceding claims further comprising ing the second plurality of particles in an inhalation delivery consumable t.
11. A dry powder composition, comprising: 20 a plurality of particles formed of ne, a sugar, and an amino acid, wherein about 90% by volume of the particles have a particle size of less than about 28 micrometres, and about 50% by volume of the particles have a particle size of less than about 1.35 micrometres. and about 10% by volume of the particles have a particle size of less than about 0465 micrometres.
12. The dry powder ition according to claim 11 n, the nicotine comprises nicotine lactate, nicotine pyruvate, nicotine citrate, nicotine aspartate, and the sugar comprises trehalose and the amino acid comprises leucine.
13. The dry powder ition according to claim 11 or 12, comprising about 5 to about 15 wt% nicotine.
14. The dry powder composition of any one of claims 11 to 13, comprising about 60 wt% to about 95 wt% sugar, and about 1 wt% to about 10 wt% amino acid.
15. An inhalation delivery consumable element containing the dry powder composition of any one of claims 11 to 14. WO 02779 ’/—— 100 104 102
NZ747726A 2016-06-30 2017-06-21 Nicotine particles NZ747726A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16177156.3 2016-06-30

Publications (1)

Publication Number Publication Date
NZ747726A true NZ747726A (en)

Family

ID=

Similar Documents

Publication Publication Date Title
US12048762B2 (en) Nicotine particles
US20210361567A1 (en) Nicotine particles and compositions
JP6672258B2 (en) Nicotine preparation and method for producing the same
RU2484823C2 (en) Compositions for treating parkinson's disease
EP2398464B1 (en) Pharmaceutical composition for inhalation
WO2003035051A2 (en) The use of proton sequestering agents in drug formulations
AU2003273273B2 (en) Trospium containing compositions
JP2023171770A (en) Inhalable composition of clofazimine and methods of use thereof
EP2368548B1 (en) Dry powder pharmaceutical composition for inhalation
NZ747726A (en) Nicotine particles
AU2021332085B2 (en) Glucosidase inhibitors for the treatment and prevention of pulmonary infections
NZ747471A (en) Nicotine particles and compositions
US20240299379A1 (en) Compositions of clofazimine and amikacin for pulmonary administration in the treatment of respiratory diseases
IL263540B2 (en) Microparticles comprising a sulphur-containing compound
Ambrus et al. Development of dry powder carrier systems for pulmonary application
CN118806738A (en) Pharmaceutical preparation for inhalation and application thereof in medicine
Ambrus et al. Aerodynamic and structural evaluation of microcomposites containing meloxicam potassium